User profiles for Mark A. Espeland
Mark EspelandWake Forest School of Medicine Verified email at wakehealth.edu Cited by 52312 |
Sodium reduction and weight loss in the treatment of hypertension in older persons: a randomized controlled trial of nonpharmacologic interventions in the elderly …
Context.—Nonpharmacologic interventions are frequently recommended for treatment of
hypertension in the elderly, but there is a paucity of evidence from randomized controlled trials …
hypertension in the elderly, but there is a paucity of evidence from randomized controlled trials …
Effect of structured physical activity on prevention of major mobility disability in older adults: the LIFE study randomized clinical trial
…, S Blair, DE Bonds, TS Church, MA Espeland… - Jama, 2014 - jamanetwork.com
Importance In older adults reduced mobility is common and is an independent risk factor for
morbidity, hospitalization, disability, and mortality. Limited evidence suggests that physical …
morbidity, hospitalization, disability, and mortality. Limited evidence suggests that physical …
Effect of estrogen plus progestin on global cognitive function in postmenopausal women: the Women's Health Initiative Memory Study: a randomized controlled trial
ContextObservational studies have suggested that postmenopausal hormone treatment may
improve cognitive function, but data from randomized clinical trials have been sparse and …
improve cognitive function, but data from randomized clinical trials have been sparse and …
Effect of lovastatin on early carotid atherosclerosis and cardiovascular events. Asymptomatic Carotid Artery Progression Study (ACAPS) Research Group.
…, WB Applegate, RP Byington, MA Espeland… - Circulation, 1994 - Am Heart Assoc
BACKGROUND HMG CoA reductase inhibitors (or statins), a new class of lipid-lowering
compounds, have raised expectations for more widespread use than that of the older lipid-…
compounds, have raised expectations for more widespread use than that of the older lipid-…
Conjugated equine estrogens and global cognitive function in postmenopausal women: Women's Health Initiative Memory Study
MA Espeland, SR Rapp, SA Shumaker, R Brunner… - Jama, 2004 - jamanetwork.com
ContextThe Women's Health Initiative Memory Study (WHIMS) previously reported that estrogen
plus progestin therapy does not protect cognition among women aged 65 years or older…
plus progestin therapy does not protect cognition among women aged 65 years or older…
[PDF][PDF] Metformin as a tool to target aging
N Barzilai, JP Crandall, SB Kritchevsky, MA Espeland - Cell metabolism, 2016 - cell.com
Aging has been targeted by genetic and dietary manipulation and by drugs in order to
increase lifespan and health span in numerous models. Metformin, which has demonstrated …
increase lifespan and health span in numerous models. Metformin, which has demonstrated …
Evaluation of the azoospermic patient
JP Jarow, MA Espeland, LI Lipshultz - The Journal of urology, 1989 - Elsevier
Azoospermia is found in up to 10 to 20 per cent of the men who present to an infertility clinic.
The main causes are testicular failure and ductal obstruction. Testicular biopsy remains the …
The main causes are testicular failure and ductal obstruction. Testicular biopsy remains the …
[HTML][HTML] Physical rehabilitation for older patients hospitalized for heart failure
…, B Upadhya, SD Reed, MA Espeland… - … England Journal of …, 2021 - Mass Medical Soc
Background Older patients who are hospitalized for acute decompensated heart failure
have high rates of physical frailty, poor quality of life, delayed recovery, and frequent …
have high rates of physical frailty, poor quality of life, delayed recovery, and frequent …
[HTML][HTML] Menopausal hormone therapy and long-term all-cause and cause-specific mortality: the Women's Health Initiative randomized trials
…, KC Johnson, LW Martin, SA Shumaker, MA Espeland… - Jama, 2017 - jamanetwork.com
Importance Health outcomes from the Women’s Health Initiative Estrogen Plus Progestin
and Estrogen-Alone Trials have been reported, but previous publications have generally not …
and Estrogen-Alone Trials have been reported, but previous publications have generally not …
Effect of linagliptin vs glimepiride on major adverse cardiovascular outcomes in patients with type 2 diabetes: the CAROLINA randomized clinical trial
…, SE Kahn, OE Johansen, B Zinman, MA Espeland… - Jama, 2019 - jamanetwork.com
Importance Type 2 diabetes is associated with increased cardiovascular risk. In placebo-controlled
cardiovascular safety trials, the dipeptidyl peptidase-4 inhibitor linagliptin …
cardiovascular safety trials, the dipeptidyl peptidase-4 inhibitor linagliptin …